购物车
- 全部删除
- 您的购物车当前为空
Anti-PD-L1 Antibody (9Z343) 是一种 Mouse 抗体,靶向 PD-L1。Anti-PD-L1 Antibody (9Z343) 可用于 WB。
Anti-PD-L1 Antibody (9Z343) 是一种 Mouse 抗体,靶向 PD-L1。Anti-PD-L1 Antibody (9Z343) 可用于 WB。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
20 μL | ¥ 785 | 5日内发货 | |
100 μL | ¥ 1,684 | 5日内发货 |
产品描述 | Anti-PD-L1 Antibody (9Z343) is a Mouse antibody targeting PD-L1. Anti-PD-L1 Antibody (9Z343) can be used in WB. |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 9Z343 |
交叉反应 | Human |
验证活性 | 1. Anti-PD-L1 mouse monoclonal antibody at 1:500 dilution. -Lane A: K562 Whole Cell Lysate. -Lane B: THP1 Whole Cell Lysate. -Lane C: Raji Whole Cell lysate. -Lysates/proteins at 30 μg per lane. -Secondary -Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution. -Developed using the ECL technique. -Performed under reducing conditions. -Predicted band size:33 kDa. -Observed band size:45 kDa. 2. B7-H1 was immunoprecipitated using: -Lane A:0.5 mg K562 Whole Cell Lysate. -4µL anti-B7-H1 mouse monoclonal antibody and 60 μg of Immunomagnetic beads Protein A/G. -Primary antibody: -Anti-B7-H1 mouse monoclonal antibody, at 1:100 dilution. -Secondary antibody: -Clean-Blot IP Detection Reagent (HRP) at 1:1000 dilution. -Developed using the ECL technique. -Performed under reducing conditions. -Predicted band size: 33 kDa. -Observed band size:45 kDa |
应用 | WB |
推荐剂量 | WB: 1:500-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human PD-L1/B7-H1/CD274 (rh PD-L1/B7-H1/CD274; TMPY-04343; NP_054862.1; Met1-Thr239). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Blockade: Blocking AntibodiImmune Checkpoint Blockade: PD-L1 / B7-H1 / CImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: ICC AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyPD-L1 / B7-H1 / CD274 Immune Checkpoint ProteTargeted Therapy |
偶联 | Unconjugated |
免疫原 | Recombinant Human PD-L1/B7-H1/CD274 Protein (TMPY-04343) |
抗原种属 | Human |
研究领域 | Cancer Drug Targets |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容